5Bootcov M R, Bauskin A R, Valenzuela S M, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily [J] . Proc Natl Acad Sci USA, 1997,9 (21) :11514-11519.
6Bauskin A R, Brown D A, Kuffner T, et al. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer[J]. Cancer Res,2006, 15,66(10) :4983-4986.
8Taberuero J. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents [ J ]. Mol Cancer Res, 2007,5 (3) :203-220.
9Katsabeki- Katsafli A, Kerenidi T, Kostikas K, et al. Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer [ J ]. Lung cancer, 2008, 60 ( 2 ) : 271-276.
10Skobe M, Hawighorst T,Jackson D G, et al. Induction of tumor lym- phangiogenesis by VEGF-C promotes breast cancer metastasis [ J ]. Nat med,2001,7(2) :192-198.
5Alatas F, Alatas O, Metintas M, et al. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions[ J]. Lung Cancer,2001,31 ( 1 ) :9-16.
8Zhai R, Liu G, Zhou W, et al. Vascular endothelial growth factor genotypes,haplotypes, gender, and the risk of non-small cell lung cancer[J]. Clin Cancer Res,2008,14(20) :612 -615.
9Bernard C, Jean-Louis C, Laurent H, et al. Diagnostic value of inter- leukine-6,transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions [ J ]. Respiratory Medi- cine,2008,102:1708 - 1711.
10Kalomenidis I, Kollintza A, Sigala I, et al. Angiopoietin-2 levels are elevated in exudative pleural effusions [ J ]. Chest, 2006,129 ( 5 ) :1259 -1266.
5Van der Bij S ,Schaake E, Koffijberg H. Markers for the non-invasive diagnosis of mesothelioma: a systematic review[J]. BrJ Cancer, 2011, 104(8): 1325-1333.
6Dikensoy O, Celik N, Kul S. Ischemia modified albumin in the differential diagnosis ofpleural effusions[J]. Resprir Me-d, 2011, 105 (11): 1712-1717.
7Rodriguez-Pineiro AM, Blanco-Prieto S, Sanchez-Otero N. On the identification of biomarkers for non-small cell lung ca-ncer in serum and pleural effusion[J]. J Proteomics, 2010, 73 (8) :1511-1522.
8Zhang JX, Xie CM ,Zhu ZW. Potential role of AQP1 and VEGF in the development of malignant pleural effusion in m-ice[J]. Med Oncol, 2012 ; 29(2): 656-662.
9Rashid-KolvearF, Taboski MA, Nguyen J. Troglitazone sup-presses telomerase activity independently of PPAR gamma in estrogen-receptor negative breast cancer cells[J]. BMC Cancer, 2010, 10(1): 390.
